GET DAILY SIGNALSSurgePays (SURG): A Focused Look at Prepaid Wireless and Neighborhood Fintech
Key Takeaways
- SURG is the ticker for SurgePays, Inc., a U.S.-based financial technology (fintech) and telecommunications company serving underbanked and underserved consumers.
- The company is headquartered in Bartlett, Tennessee, and was founded in 2006, with Kevin Cox serving as Chief Executive Officer.
- SurgePays operates through wireless brands, a mobile virtual network enabler (MVNE) platform, and point-of-sale (POS) fintech services distributed largely through convenience stores.
- Revenue is driven primarily by prepaid and subsidized wireless services, wireless "top-up" transactions, and retail fintech offerings.
- The company's financial profile has been shaped by the wind-down of the federal Affordable Connectivity Program (ACP), a major former revenue source.
Introduction
SurgePays, Inc. focuses on linking subprime, underbanked, and underserved consumers with essential wireless and financial services. The company follows an asset-light approach by leasing capacity from major carriers rather than building its own network, and it reaches customers through a broad network of independent convenience stores and local retailers. This setup positions SURG directly where many value-conscious shoppers already buy everyday items, creating a distinct presence in the prepaid wireless and neighborhood fintech space. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Company Overview and History
SurgePays was founded in 2006 and is based in Bartlett, Tennessee. It trades on the Nasdaq under the ticker SURG. The business has grown through a mix of organic expansion and acquisitions, developing a set of brands and technology platforms aimed at consumers who often lack traditional banking ties or steady access to mainstream wireless plans. From what I see, this history helps explain the company’s current emphasis on recurring revenue streams outside of past subsidy programs.
The operations break down into several related areas. Wireless activities include a Mobile Virtual Network Operator (MVNO) that delivers prepaid and subsidized mobile broadband, voice, and text services. There is also an MVNE platform called HERO that provides other firms with the backend tools to run their own wireless brands. Finally, the POS and fintech segment handles transaction processing and prepaid top-ups at convenience stores and independent retailers.
Business Model and Revenue Sources
SurgePays targets a segment that larger telecom and financial firms frequently overlook. Its main revenue streams consist of subsidized wireless services through the federal Lifeline program, prepaid wireless brands such as LinkUp Mobile available in the U.S., Mexico, and Canada, wireless top-up and fintech transactions processed via a POS platform at retail locations, and B2B enablement through the HERO MVNE platform that supplies airtime, SIM provisioning, billing, and support to third-party brands. One thing that stands out is how the company has shifted focus after the Affordable Connectivity Program (ACP) wound down, moving toward recurring, unsubsidized revenue from its prepaid offerings, top-up platform, and MVNE services. This transition remains central to the current financial picture.
Why Investors Follow SURG
Investors track SURG because it sits at the overlap of two sizable and lasting markets: affordable connectivity and neighborhood financial services. Millions of U.S. consumers depend on prepaid wireless and alternative financial products, and the company’s convenience-store distribution network provides direct access to this group. Potential growth areas include the reach of its retail footprint, the recurring nature of wireless subscribers, and the chance to cross-sell products to the same customers. The HERO platform also creates a scalable wholesale revenue opportunity as partner brands expand. As a smaller operator, results can move noticeably with shifts in government programs, retail ties, and subscriber costs, which keeps the stock on the radar for those following underserved-market themes.
Risks and Important Considerations
Several points deserve attention before considering SURG. Financial results have depended significantly on government subsidy programs like the ACP and Lifeline, which can change with policy and bring regulatory risk. The company competes in crowded markets against larger prepaid wireless and fintech providers with more resources. As a small-capitalization firm, shares tend to be more volatile and less liquid than those of bigger companies. Periods of operating losses have occurred during the business-model transition and growth investments. Reliance on convenience-store distribution and third-party carrier networks also means partner relationships and carrier agreements remain key operational factors. These elements make the route to sustained profitability an important focus for investors.
Using AI Tools in My Research
I have found Tickeron’s AI Screener helpful when reviewing smaller names like this one. It lets me apply technical indicators, fundamentals, volatility measures, trends, and AI-generated signals across industries and price patterns to surface ideas that fit a particular strategy. For comparing opportunities in fintech or telecom niches, it serves as a practical starting point without replacing deeper fundamental work.
Conclusion
SurgePays holds a distinct place in the U.S. telecom and fintech landscape by targeting underbanked and underserved consumers with prepaid wireless services, a B2B wireless-enablement platform, and convenience-store fintech transactions. Its asset-light model and retail distribution network differentiate it from larger network-owning carriers, while dependence on government subsidy programs and a competitive setting remain important considerations. For investors interested in affordable-connectivity and alternative-financial-services themes, SURG offers a focused though higher-risk way to follow these markets.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
SURG's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for SURG turned positive on October 21, 2026. Looking at past instances where SURG's MACD turned positive, the stock continued to rise in 44 of 46 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
SURG moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for SURG crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.
Following a +7.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where SURG advanced for three days, in 203 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
The 10-day RSI Indicator for SURG moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 28 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 41 cases where SURG's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 88%.
The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SURG as a result. In 81 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SURG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
SURG broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SURG entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.425) is normal, around the industry mean (2.292). P/E Ratio (-0.111) is within average values for comparable stocks, (-7.252). Projected Growth (PEG Ratio) (0.474) is also within normal values, averaging (8.005). Dividend Yield (0.000) settles around the average of (0.132) among similar stocks. P/S Ratio (0.048) is also within normal values, averaging (5.777).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. SURG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SURG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry MajorTelecommunications
Advertisement